Unknown

Dataset Information

Lithium for the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Discontinuation Study.


ABSTRACT:

Objective

This study examined the role of lithium in the maintenance treatment of pediatric patients with bipolar I disorder (BP-I).

Method

Participants aged 7 to 17 years who presented with a manic or mixed episode received 24 weeks of lithium treatment in one of two multiphase studies, the Collaborative Lithium Trials (CoLT 1 and CoLT 2). Responders were randomized to continue lithium or to be cross-titrated to placebo for up to 28 weeks. The primary outcome measure was relative risk of study discontinuation for any reason.

Results

A Cox regression analysis found that those who continued treatment with lithium (n = 17) had a lower hazard ratio compared to those who received placebo (n = 14) (p = .015)]. The vast majority of discontinuations were due to mood symptom

SUBMITTER: Findling RL 

PROVIDER: S-EPMC6414078 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature